Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2023-06-30 00:00:00 ET · period of report 2023-06-28 · accession 0001104659-23-077015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | 2023-06-28 | RCUS | GILEAD SCIENCES, INC. | 10% | P - Purchase | $19.26 | +1.01M | 14.82M | +7% | +$19.45M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-28 | P | A | 1,010,000 | $19.26 | 14,823,029 | D | — | — |